Neurontin Pain Claim Follows Cmte. Preference For Individual Etiologies

Pfizer's Neurontin postherpetic neuralgia indication closely follows a recent advisory committee recommendation that indications for individual etiologies of neuropathic pain would be preferable to a broad claim